Östermalmstorg 1
Stockholm 114 42
Sweden
https://www.odipharma.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 1
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Derek Simmross | CEO & Director | N/A | N/A | N/A |
Ms. Karina Kilinski | Sales Director & Director | N/A | N/A | N/A |
Dr. Markus Fritzsche | Head of Research | N/A | N/A | N/A |
Thomas Cramer | Head of Sales Cosmetics | N/A | N/A | N/A |
ODI Pharma AB (publ), a pharmaceutical company, produces and distributes pharmaceutical cannabis and cosmetics products in Europe. The company offers cannabidiol-infused facial cream, facial mask, and body balm under the Kandol. brand name through kandol.net. The company was founded in 2018 and is based in Stockholm, Sweden.
ODI Pharma AB (publ)s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.